Format

Send to

Choose Destination
Arch Gen Psychiatry. 1980 Jun;37(6):642-7.

beta-Endorphin. Intravenous infusion causes behavioral change in psychiatric inpatients.

Abstract

Ten depressed and eight schizophrenic patients received synthetic human beta-endorphin infusions in a double-blind, placebo-controlled, crossover design. Physicians' and nurses' ratings and patients' self-ratings were used to measure behavioral change. Depressed patients improved significantly two to four hours after beta-endorphin treatment when compared with placebo treatment. There was no significant change in the schizophrenic patients as a group, although six of eight worsened after beta-endorphin treatment. No significant behavioral effects were observed during the infusions themselves or on postinfusion days.

PMID:
7387336
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center